50 MG TAB
Rs 160 10 % Off
Package size
Estimate Delivery by:
Delivering to
Easy 7 days return available
50 MG TAB
Remozen V Tablet combines Remogliflozin and Vildagliptin to manage Type II diabetes effectively. Remogliflozin, an SGLT2 inhibitor, works by increasing glucose excretion through urine, while Vildagliptin, a DPP-4 inhibitor, enhances insulin secretion and decreases glucagon levels, resulting in better glycemic control. This medication is recommended for patients who do not achieve adequate blood sugar control with diet and exercise alone. It is essential to follow the prescribed dosage and consult a healthcare provider, especially if there are pre-existing conditions. Common side effects include gastrointestinal issues, dizziness, and infections. Regular monitoring of blood sugar levels is advised for optimal results.
Product Highlights and Usage:
Combination Therapy: Contains Remogliflozin and Vildagliptin for effective diabetes management. Type II Diabetes Control: Helps improve glycemic control when diet and exercise are insufficient. Dual Mechanism: Remogliflozin promotes glucose excretion via urine; Vildagliptin enhances insulin secretion and decreases glucagon levels. Usage Precautions: Not suitable for patients with severe kidney, liver, or heart problems; avoid during pregnancy and breastfeeding. Common Side Effects: Includes constipation, diarrhea, dizziness, headache, urinary tract infection, and upper respiratory tract infection.
How it works:
This medication helps reduce blood glucose by increasing the excretion of glucose via urine. It achieves this by inhibiting certain proteins in the body responsible for the reabsorption of glucose in the kidneys. By blocking the action of these proteins, the medication prevents glucose reabsorption, leading to increased urinary glucose excretion, which helps manage type 2 diabetes in affected individuals. Additionally, it controls blood glucose levels by stimulating the pancreas to produce more insulin and less glucagon, resulting in lower blood sugar levels and better overall glucose control.
Directions for use:
Take this medication as advised by your physician. Do not crush or chew it; swallow the tablet whole with a glass of water. Your doctor will determine the appropriate dose and duration based on your age, body weight, and medical condition.
Warning & Precaution:
PREGNANCY REMOZEN V TABLET is generally not recommended for use in pregnant women. However, consult your doctor for advice. BREASTFEEDING REMOZEN V TABLET is not recommended for use in breastfeeding women, as it may pass through breast milk. Consult your doctor for advice. DRIVING AND USING MACHINES Use with caution: Do not drive or operate machines if you experience dizziness, shaking, sweating, or changes in vision after taking REMOZEN V TABLET. ALCOHOL Consult your doctor: Avoid alcohol consumption while taking REMOZEN V TABLET, as it may increase your blood sugar levels. KIDNEY REMOZEN V TABLET is not recommended for use in patients with moderate to severe renal impairment. Consult your doctor before taking this medicine. LIVER REMOZEN V TABLET is not recommended for use in patients with moderate to severe liver impairment. Consult your doctor for advice before taking this medicine. ALLERGY Do not take REMOZEN V TABLET if you are allergic to Remogliflozin, Vildagliptin, or any other ingredients in this medicine. HEART DISEASE Use with caution: REMOZEN V TABLET should be used cautiously in patients suffering from heart failure. Consult your doctor before taking it. USE IN PEDIATRICS REMOZEN V TABLET is not recommended for use in children and adolescents under 18 years of age. Consult your doctor for advice. USE IN GERIATRICS REMOZEN V TABLET is not recommended for use in elderly patients aged 65 years and above. Consult your doctor before taking it.
Super Admin
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s
Recent Posts
-
October 18, 2015
-
October 18, 2015
Products
-
275$
-
137.64$